TPP: Record numbers of submissions show opposition to more rights for global corporations
April 6, 2016 Media Release: “The Joint Standing Committee on Treaties Inquiry into the Trans-Pacific trade deal received a record number of 175 substantial submissions, most of which are critical of the ways in which the TPP gives additional monopoly rights to global pharmaceutical corporations and permits all foreign corporations to sue governments over changes in domestic legislation,” AFTINET Convener Dr Patricia Ranald said today.